RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19675284http://www.w3.org/2000/01/rdf-schema#comment"Mast cells have been shown to play a role in development and persistence of various inflammatory bladder disorders. Mast cell-derived tryptase specifically activates protease-activated receptor-2 (PAR-2), and PAR-2 is known to be involved in inflammation. We investigated whether mast cells participate in increase of cyclooxygenase-2 (COX-2) protein abundance in urothelium/suburothelium of bladders of mice subsequent to cyclophosphamide (CYP)-induced bladder inflammation. We also used primary cultures of human urothelial cells to investigate cellular mechanisms underlying activation of PAR-2 resulting in increased COX-2 expression. We found that treatment of mice with CYP (150 mg/kg ip) increased COX-2 protein abundance in bladder urothelium/suburothelium 3, 6, and 24 h after CYP (P < 0.01), and increased COX-2 protein abundance was prevented by treatment of mice with the mast cell stabilizer sodium cromolyn (10 mg/kg ip) for 4 consecutive days before CYP treatment. Incubation of freshly isolated mouse urothelium/suburothelium with a selective PAR-2 agonist, 2-furoyl-LIGRLO-amide (3 microM), also increased COX-2 protein abundance (P < 0.05). We further demonstrated that 2-furoyl-LIGRLO-amide (3 microM) increased COX-2 mRNA expression and protein abundance in primary cultures of human urothelial cells (P < 0.01), and the effects of PAR-2 activation were mediated primarily by the ERK1/2 MAP kinase pathway. These data indicate that there are functional interactions among mast cells, PAR-2 activation, and increased expression of COX-2 in bladder inflammation."xsd:string
http://purl.uniprot.org/citations/19675284http://purl.org/dc/terms/identifier"doi:10.1152/ajpregu.00310.2009"xsd:string
http://purl.uniprot.org/citations/19675284http://purl.uniprot.org/core/author"Wang P."xsd:string
http://purl.uniprot.org/citations/19675284http://purl.uniprot.org/core/author"Wang Z.Y."xsd:string
http://purl.uniprot.org/citations/19675284http://purl.uniprot.org/core/author"Bjorling D.E."xsd:string
http://purl.uniprot.org/citations/19675284http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19675284http://purl.uniprot.org/core/name"Am J Physiol Regul Integr Comp Physiol"xsd:string
http://purl.uniprot.org/citations/19675284http://purl.uniprot.org/core/pages"R1127-35"xsd:string
http://purl.uniprot.org/citations/19675284http://purl.uniprot.org/core/title"Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells."xsd:string
http://purl.uniprot.org/citations/19675284http://purl.uniprot.org/core/volume"297"xsd:string
http://purl.uniprot.org/citations/19675284http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19675284
http://purl.uniprot.org/citations/19675284http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19675284
http://purl.uniprot.org/uniprot/#_A0A087WPT2-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_D9MWI3-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_P35354-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_Q3TU81-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_Q3UMR6-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_P55085-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_P55086-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_Q05769-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_Q3TYP1-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_Q7TMV2-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_Q8IZA9-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284
http://purl.uniprot.org/uniprot/#_Q6ZYK7-mappedCitation-19675284http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19675284